Arcenas, R.C. 2017. Diagnostic Molecular Pathology.
Bonten, Marc J M and Weinstein, Robert A 2016. Making sense of universal screening for MRSA. The Lancet Infectious Diseases, Vol. 16, Issue. 3, p. 272.
Doll, Michelle Hewlett, Angela L. and Bearman, Gonzalo 2016. Infection Prevention in the Hospital from Past to Present: Evolving Roles and Shifting Priorities. Current Infectious Disease Reports, Vol. 18, Issue. 5,
Edmiston, Charles E. Ledeboer, Nathan A. Buchan, Blake W. Spencer, Maureen Seabrook, Gary R. and Leaper, David 2016. Is Staphylococcal Screening and Suppression an Effective Interventional Strategy for Reduction of Surgical Site Infection?. Surgical Infections, Vol. 17, Issue. 2, p. 158.
Lee, Hojin and Lee, Hyuck 2016. Clinical and Economic Evaluation of Multidrug-ResistantAcinetobacter baumanniiColonization in the Intensive Care Unit. Infection & Chemotherapy, Vol. 48, Issue. 3, p. 174.
Dananché, Cédric Bénet, Thomas Allaouchiche, Bernard Hernu, Romain Argaud, Laurent Dauwalder, Olivier Vandenesch, François and Vanhems, Philippe 2015. Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study. Critical Care, Vol. 19, Issue. 1, p. 38.
Ariza-Heredia, Ella J. and Chemaly, Roy F. 2014. Infection Control Practices in Patients With Hematological Malignancies and Multidrug-Resistant Organisms: Special Considerations and Challenges. Clinical Lymphoma Myeloma and Leukemia, Vol. 14, p. S104.
Esposito, Susanna Terranova, Leonardo Zampiero, Alberto Ierardi, Valentina Rios, Walter Peves Pelucchi, Claudio and Principi, Nicola 2014. Oropharyngeal and nasal Staphylococcus aureus carriage by healthy children. BMC Infectious Diseases, Vol. 14, Issue. 1,
Jung, Euihan Byun, Sookjin Lee, Hojin Moon, Sang Yi and Lee, Hyuck 2014. Vancomycin-resistant Enterococcus colonization in the intensive care unit: Clinical outcomes and attributable costs of hospitalization. American Journal of Infection Control, Vol. 42, Issue. 10, p. 1062.
Larsen, Jesper David, Michael Z. Vos, Margreet C. Coombs, Geoffrey W. Grundmann, Hajo Harbarth, Stephan Voss, Andreas and Skov, Robert L. 2014. Preventing the introduction of meticillin-resistant Staphylococcus aureus into hospitals. Journal of Global Antimicrobial Resistance, Vol. 2, Issue. 4, p. 260.
Lindsay, Jodi A. 2014. Evolution of Staphylococcus aureus and MRSA during outbreaks. Infection, Genetics and Evolution, Vol. 21, p. 548.
Rosko, Ashley E. Corriveau, Mark Suwantarat, Nuntra Arfons, Lisa Treasure, Michelle Parker, Pamela Jacobs, Michael Fu, Pingfu Salata, Robert and Lazarus, Hillard M. 2014. Vancomycin-resistant enterococci infection: not just for the transplanted. Leukemia & Lymphoma, Vol. 55, Issue. 6, p. 1320.
Sharma, Yukti Jain, Sanjay Singh, Harshvardhan and Govil, Vasudha 2014. Staphylococcus aureus: Screening for Nasal Carriers in a Community Setting with Special Reference to MRSA. Scientifica, Vol. 2014, p. 1.
Byun, Sook-Jin and Kang, Jiyeon 2013. Risk Factors and Clinical Outcomes for Vancomycin-Resistant Enterococcus Colonization on Intensive Care Unit Admission. Journal of Korean Academy of Nursing, Vol. 43, Issue. 2, p. 287.
Edmiston, Charles E. Leaper, David and Kiernan, Martin 2013. The Yin and Yang of pre-operative screening for meticillin resistant and sensitive Staphylococcus aureus (MRSA and MSSA): Does the extra effort and cost of suppression reduce surgical site infections?. Wound Medicine, Vol. 1, p. 7.
Hong, Sung Kuk Kim, Taek Soo Park, Kyoung Un Kim, Jae-Seok and Kim, Eui-Chong 2013. Active Surveillance for Multidrug-resistant Organisms. Annals of Clinical Microbiology, Vol. 16, Issue. 2, p. 53.
Huang, Susan S. Septimus, Edward Kleinman, Ken Moody, Julia Hickok, Jason Avery, Taliser R. Lankiewicz, Julie Gombosev, Adrijana Terpstra, Leah Hartford, Fallon Hayden, Mary K. Jernigan, John A. Weinstein, Robert A. Fraser, Victoria J. Haffenreffer, Katherine Cui, Eric Kaganov, Rebecca E. Lolans, Karen Perlin, Jonathan B. and Platt, Richard 2013. Targeted versus Universal Decolonization to Prevent ICU Infection. New England Journal of Medicine, Vol. 368, Issue. 24, p. 2255.
Kabbani, Dima Weir, Susan K. Berg, Gretchen Chien, Gina C. Strymish, Judith and Gupta, Kalpana 2013. Cohorting based on nasal methicillin-resistant Staphylococcus aureus status: An opportunity to share more than a room. American Journal of Infection Control, Vol. 41, Issue. 5, p. 401.
Lee, Seungok Park, Yeon-Joon Park, Kang-Gyun Jekarl, Dong Wook Chae, Hyojin Yoo, Jin-Kyung Seo, Sin Won Choi, Jung Eun Lim, Jung Hye Heo, Seon Mi and Seo, Ju Hee 2013. Comparative Evaluation of Three Chromogenic Media Combined with Broth Enrichment and the Real-Time PCR-Based Xpert MRSA Assay for Screening of Methicillin-ResistantStaphylococcus aureusin Nasal Swabs. Annals of Laboratory Medicine, Vol. 33, Issue. 4, p. 255.
Lee, Bruce Y. Singh, Ashima Bartsch, Sarah M. Wong, Kim F. Kim, Diane S. Avery, Taliser R. Brown, Shawn T. Murphy, Courtney R. Yilmaz, S. Levent and Huang, Susan S. 2013. The Potential Regional Impact of Contact Precaution Use in Nursing Homes to Control Methicillin-Resistant Staphylococcus aureus. Infection Control & Hospital Epidemiology, Vol. 34, Issue. 02, p. 151.
Legislation aimed at controlling antimicrobial-resistant pathogens through the use of active surveillance cultures to screen hospitalized patients has been introduced in at least 2 US states. In response to the proposed legislation, the Society for Healthcare Epidemiology of America (SHEA) and the Association of Professionals in Infection Control and Epidemiology (APIC) have developed this joint position statement. Both organizations are dedicated to combating healthcare-associated infections with a wide array of methods, including the use of active surveillance cultures in appropriate circumstances. This position statement reviews the proposed legislation and the rationale for use of active surveillance cultures, examines the scientific evidence supporting the use of this strategy, and discusses a number of unresolved issues surrounding legislation mandating use of active surveillance cultures. The following 5 consensus points are offered. (1) Although reducing the burden of antimicrobial-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), is of preeminent importance, APIC and SHEA do not support legislation to mandate use of active surveillance cultures to screen for MRSA, VRE, or other antimicrobial-resistant pathogens. (2) SHEA and APIC support the continued development, validation, and application of efficacious and cost-effective strategies for the prevention of infections caused by MRSA, VRE, and other antimicrobial-resistant and antimicrobial-susceptible pathogens. (3) APIC and SHEA welcome efforts by healthcare consumers, together with private, local, state, and federal policy makers, to focus attention on and formulate solutions for the growing problem of antimicrobial resistance and healthcare-associated infections. (4) SHEA and APIC support ongoing additional research to determine and optimize the appropriateness, utility, feasibility, and cost-effectiveness of using active surveillance cultures to screen both lower-risk and high-risk populations. (5) APIC and SHEA support stronger collaboration between state and local public health authorities and institutional infection prevention and control experts.
This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.